True 2 Beauty Appoints New CEO to Lead Global Branding of "Libigrow" Family of Products

  True 2 Beauty, Inc. (PINKSHEETS: TRTB) (the "Company"), a leading manufacturer and distributor of male sexual potency pills and liquid products in the United States, announced today the appointment of Mr. Alex Hbaiu as President, CEO and Director.

Mr. Hbaiu has always enjoyed and found much success in entrepreneurship. He is a graduate of the highly prestigious Milton Hershey Boarding School.

Alex was provided a full academic scholarship to attend Dickinson College where he studied Biochemistry and Economics. Mr. Hbaiu has had several accomplishments while working for Eli Lily Research Labs, publishing several research articles and findings during his employment with the institute. Alex has had the opportunity to work with some of the most talented and educated doctors and scientists in the world.

The founder of Libigrow (www.libigrow.com), Mr. Hbaiu started with very little capital and has led the growth to over $10,000,000 in sales by "word of mouth" advertising only.

Regarding this appointment Mr. Hbaiu stated, "I am honored to accept this position and with the resources being provided by True 2 Beauty we are confident in ramping up our production quickly to fill our growing order book as a result of our very successful debut at the National Association of Convenience Stores (NACS) trade show in Atlanta last week."

About True 2 Beauty, Inc.

True 2 Beauty, Inc. is a leading manufacturer and distributor of male sexual potency pills and liquid products in the United States. The True 2 Beauty, Inc. line of current products includes Libigrow, Libigirl, Libiliquid Shots and the Libiliquid Relaxation Drink. More information on the Company and its line of products can be found at www.libigrow.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, among others, all assumptions, expectations, predictions, intentions or beliefs about future events. You are cautioned that any such forward-looking statements are not guarantees of future performance and that a number of risks and uncertainties could cause actual results of the Company to differ materially from those anticipated, expressed or implied in the forward-looking statements. The words "believe," "expect," "anticipate," "project," "targets," "optimistic," "intend," "aim," "will" or similar expressions are intended to identify forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Risks and uncertainties that could cause actual results to differ materially from those anticipated include risks related to new and existing products, product defects and any related product recall; any projections of sales, earnings, revenue, margins or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements. The Company assumes no obligation and does not intend to update any forward-looking statements, except as required by law.

For further information, please contact: Investors Relations Contact: New York World Asset Management [phone] Media Relations: Zara Hbaiu [e-mail] 1-888-942-5350